Noom Med Plans & Pricing
US$ 29.18
glp-1 drugs side effects Receptor Agonists Struggling with GLP-1 therapy side
Description
For many patients, the result was access to affordable alternatives at a fraction of the price of branded products
A study in The New England Journal of Medicine showed that tirzepatide (a dual GLP1/GIP receptor agonist) significantly reduced symptoms of OSA and weight in people with moderate to severe OSA and obesity
GLP-1 is a small peptide hormone released from gastrointestinal L cells upon food intake
doi: 10.1016/j.metabol.2020.154272 25 CarusoICignarelliALaviolaLGiorginoF
Consult your OB-GYN and pediatrician to evaluate your individual risk-benefit profile before starting treatment
